Yohimbine Hydrochloride (CAS 65-19-0) is a high-purity vasodilator API, extracted from the bark of Pausinystalia yohimbe and refined via advanced purification processes. Its core mechanism acts as a selective alpha-2 adrenergic receptor antagonist, dilating peripheral blood vessels, improving blood circulation, and enhancing tissue perfusion. Produced under GMP-compliant standards, it ensures consistent bioactivity, ultra-low impurity levels, and compliance with international pharmaceutical and nutraceutical quality specifications.